Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis

Eric Lawitz, Mihály Makara, Ulus Salih Akarca, Paul J. Thuluvath, Liliana Lucia Preotescu, Peter Varunok, Rosa Ma Morillas, Coleen Hall, Niloufar Mobashery, Rebecca Redman, Tami Pilot-Matias, Regis A. Vilchez, Christophe Hézode

Research output: Contribution to journal › Article › peer-review

77 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science